Ledger.Open graph →
SEC Form D · Amendment · filed August 8, 2024

Noveome Biotherapeutics, Inc

Offering
$51.3M
Sold
$36.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PITTSBURGH, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Steven Shores · Atlanta, GADirectorHouman Hemmati · Pittsburgh, PADirectorGretchen Kraemer · Pittsburgh, PAExecGretchen Kraemer · Pittsburgh, PAExecMatt Wan · San Francisco, CAExecBlackfin Real Estate Investors, LLC · Arlington, VADirectorAndrew W. Buchanan · Arlington, VADirectorEric Keller · Pittsburgh, PADirectorMichael Kaufman · Pittsburgh, PADirectorCraig Nemiroff · Pittsburgh, PADirectorMichael Kaufman · Pittsburgh, PADirectorWilliam Hicks · San Francisco, CADirectorPatrick Welch · Pittsburgh, PAExecRobert Langer · Pittsburgh, PADirectorEric Keller · Pittsburgh, PADirectorCraig Nemiroff · Pittsburgh, PADirectorRonald Poropatich · Pittsburgh, PADirectorHouman Hemmati · Pittsburgh, PADirectorRonald Poropatich · Pittsburgh, PADirectorDaniel P. Gould · Pacifica, CADirectorMichael Huber · New York, NYDirectorDouglas Root · Arlington, VADirectorAndrew J. Spokes · San Francisco, CAExecBradley Fishman · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗